Business   

Strides enters Japanese market

By Our Staff Reporter

BANGALORE OCT. 13. Strides Arcolab, the Bangalore based generics drug maker, has signed a development and manufacturing agreement with SORM Co., Japan, a major distributor of OTC drugs, for long-term supply of bulk drugs, OTC formulations and nutraceuticals.

Arun Kumar, Group CEO, Strides, said the tie-up was part of the company's strategy to become a "priority manufacturer'' for leading pharmaceutical companies in the regulated markets in the EU, the U.K., the U.S., South Africa, Australia/NZ and Japan. The two companies signed an MOU to form a joint venture company in Japan, to exploit the growing generics market in Japan.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• Lupin, CVC sign share purchase agreement
• CRISIL expects 6.5 p.c. rise in GDP
• Sensex zips past 4800 mark
• GE, Bechtel offer to restart DPC
• Boon or bane?
• Strides enters Japanese market
• Aurobindo Pharma's preferential issue at hefty premium
• Automatic version of Chevrolet Optra launched
• New 100 cc variant from Hero Honda
• Bharti constitutes mobility board
• Rupee hits one-week low
• Stock Market Index
• Exchange rates
• Bullion rates

Copyright © 2003, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu